We are live on ! Find out more
CVRS

CORINDUS VASCULAR ROBOTICS, INC
CVRS

Delisted

CVRS was delisted on the 28th of October, 2019.

64 hedge funds and large institutions have $136M invested in CORINDUS VASCULAR ROBOTICS, INC in 2019 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

320% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 5

174% more capital invested

Capital invested by funds: $49.8M → $136M (+$86.6M)

33% more funds holding

Funds holding: 4864 (+16)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

22% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 18

Holders
64
Holders Change
+16
Holders Change %
+33.33%
% of All Funds
1.39%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
21
Increased
14
Reduced
18
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
HM
1
HealthCor Management
New York
$34.8M
HEC
2
Hudson Executive Capital
New York
$24.8M +$4.01M +2,899,391 +26%
Capital World Investors
3
Capital World Investors
California
$18.5M +$15M +10,872,716 New
Millennium Management
4
Millennium Management
New York
$13.8M +$1.19M +863,272 +12%
MCM
5
Masters Capital Management
Georgia
$8.7M
Fidelity Investments
6
Fidelity Investments
Massachusetts
$6.8M -$1.51M -1,089,845 -22%
Vanguard Group
7
Vanguard Group
Pennsylvania
$6.59M +$2.34M +1,694,975 +81%
SSA
8
Schonfeld Strategic Advisors
New York
$3.13M +$276K +200,000 +13%
Nomura Holdings
9
Nomura Holdings
Japan
$2.1M -$139K -100,730 -8%
Bank of America
10
Bank of America
North Carolina
$1.83M +$1.45M +1,052,597 New
KCM
11
Kennedy Capital Management
Missouri
$1.74M -$412K -298,385 -23%
EI
12
EAM Investors
California
$1.41M +$1.12M +808,156 New
Geode Capital Management
13
Geode Capital Management
Massachusetts
$1.31M +$214K +155,123 +26%
BCM
14
Bridgeway Capital Management
Texas
$1.2M -$207K -150,000 -18%
EGI
15
EAM Global Investors
California
$1.02M +$814K +588,645 New
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
$959K +$494K +357,066 +184%
BlackRock
17
BlackRock
New York
$860K -$15.5K -11,236 -2%
Goldman Sachs
18
Goldman Sachs
New York
$754K +$541K +391,380 +939%
Morgan Stanley
19
Morgan Stanley
New York
$735K +$29.4K +21,289 +5%
IG
20
ING Group
Netherlands
$435K +$346K +250,000 New
Northern Trust
21
Northern Trust
Illinois
$388K +$68.1K +49,267 +28%
Deutsche Bank
22
Deutsche Bank
Germany
$374K +$265K +191,993 +824%
ECM
23
ExodusPoint Capital Management
New York
$366K +$178K +128,727 +158%
TEE
24
Tibra Equities Europe
United Kingdom
$365K +$290K +209,885 New
JP Morgan Chase
25
JP Morgan Chase
New York
$342K +$272K +196,794 New

CVRS Hedge Fund Activity: Q1 2019 in Review

64 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in CORINDUS VASCULAR ROBOTICS, INC (CVRS) for Q1 2019, worth a combined $136M — up 174% from $49.8M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new CVRS positions and 5 closed out — a net gain of 16 holders — while 14 added to existing stakes and 18 trimmed.

The largest buyer was Capital World Investors, opening a new position worth an estimated $15M. The largest seller was Fidelity Investments, cutting an estimated $1.51M.

  • 64 institutional investors held CORINDUS VASCULAR ROBOTICS, INC (CVRS) as of Q1 2019, up from 48 in Q4 2018.
  • Funds reported $136M of CORINDUS VASCULAR ROBOTICS, INC stock for Q1 2019, up 174% quarter-over-quarter.
  • 21 funds opened new CORINDUS VASCULAR ROBOTICS, INC positions in Q1 2019 and 5 closed out, a net change of +16 holders.
  • The largest CORINDUS VASCULAR ROBOTICS, INC buyer in Q1 2019 was Capital World Investors, an estimated $15M added.
  • The largest CORINDUS VASCULAR ROBOTICS, INC seller in Q1 2019 was Fidelity Investments, an estimated $1.51M sold.

Based on aggregated 13F filings for Q1 2019.